The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II trial of neoadjuvant ABI-007, carboplatin, and gemcitabine (ACG) in patients with locally advanced carcinoma of the bladder.
David C. Smith
No relevant relationships to disclose
Petros Grivas
No relevant relationships to disclose
Stephanie Daignault
No relevant relationships to disclose
Khaled Hafez
No relevant relationships to disclose
David P. Wood
No relevant relationships to disclose
Cheryl T. Lee
No relevant relationships to disclose
James E. Montie
No relevant relationships to disclose
Alon Z. Weizer
No relevant relationships to disclose
Jeffrey Montgomery
No relevant relationships to disclose
Maha Hussain
No relevant relationships to disclose